Stimulation of fibroblast proliferation

URGO is an international provider of healthcare solutions, offering a complete range of cost-effective wound management dressings – including the Urgotul, Urgocell and Urgosorb ranges.

 Other products available include the K range of compression/retention bandages, and the company’s anti-embolism hosiery – known as Preventex. URGOTUL and URGOCELL, based on Technology Lipido-Colloid (TLC), create a moist wound environment and are genuinely non-adherent – allowing painfree dressing changes. They are proven to increase stimulation of fibroblast proliferation by 45%, an essential factor in the wound healing process. TLC has now been combined with NOSF (Nano-OligoSaccharide Factor), an active compound designed to promote healing in all wounds at risk of delayed healing. Urgotul Start and Urgocell Start incorporate this technology. K Two is an innovative compression bandage system, spreading the pressure evenly between the two layers. Each bandage is printed with an etalonnage (pressure indicator) ensuring safe and accurate pressure on first application.

Latest Issues

AESCULAP ACADEMY LIVE - Circular Economy in Action

B. Braun Business Centre, Sheffield
Friday 10th July 2026

AfPP Regional Conferences: Bristol

BAWA Leisure
18th July 2026

AfPP Annual National Conference 2026

Wyboston Lakes Resort
7th – 8th August 2026

The Annual Operating Theatres Show

Manchester (Etihad)
10th September 2026

AfPP Regional Conferences: London

Cavendish Conference Centre
12th September 2026

CSC Autumn Study Day 2026

Holiday Inn, Birmingham Airport - NEC by IHG
12th October 2026